Zdrowie i gospodarka · 24/09/2012

FDA Announces Public Meeting and Request for Comments on Patient-Focused Drug Development Initiative

The Food and Drug Administration (FDA) is hosting a public meeting and seeking public comments on its patient-focused drug development initiative, which aims to incorporate patient perspectives into the approval process for new treatments. The initiative is part of the FDA's performance commitments under the Prescription Drug User Fee Act (PDUFA V).